Fakultni nemocnice Hradec Králové
Hradec Králové 50005
0 studies enrolling now · 3 studies all time
What they study most
Children Whose Mothers Received 17P and Those Who Received Vehicle in the 17P Efficacy Trial, Leukemia, Myelomonocytic, Chronic, Metastatic Breast Cancer, Myelodysplastic Syndromes
Studies at this site
- Guadecitabine (SGI-110) vs Treatment Choice in Adults With MDS or CMML Previously Treated With HMAs — Completed
- A Double-blind Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast Cancer — Completed
- A Prospective, Noninterventional Follow-Up Study of Children Aged 23 to 25 Months, Born to Mothers Who Received Hydroxyprogesterone Caproate Injection, 250 mg/mL, or Vehicle for Prevention of Preterm Birth — Completed